Table of Contents
Datamonitor's Pharmaceuticals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in Brazil, Hungary, Mexico, Poland, South Africa, and Taiwan. The report includes easily comparable data on market value, volume, segmentation and market share for the advanced emerging markets pharmaceuticals markets, plus full five-year market forecasts. It examines future problems, innovations and potential growth areas within the market.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Compares data from Brazil, Hungary, Mexico, Poland, South Africa and Taiwan, alongside individual chapters on each country. .
* Includes a five-year forecast of the industry
The advanced emerging market countries contributed $31.0 billion to the global pharmaceuticals industry in 2006, with a compound annual growth rate (CAGR) of 8.2% between 2006 and 2010 bringing this contribution to $42.5billion.
These countries are expected to reach a value of $73.1 billion in 2015, with a CAGR of 11.5% over the 2010–15 period.
Brazil holds the major share of the pharmaceuticals industry. In 2010, it accounted for 36% of the market
Among the advanced emerging market nations, Brazil is the leading country in the pharmaceuticals industry, with market revenues of $15.3 billion in 2010.
Brazil is expected to lead the pharmaceuticals industry in the advance emerging market nations, with a value of $34.4 in 2015
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
In this report, the pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2009 annual average exchange rates.
Find all the market research you need - instantly, in one place.
Talk to Louis
+1 718 618 4302
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded ...
Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...
Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...
Reportlinker.com © Copyright 2014. All rights reserved.